IFF 10-Q Details $236M Disposal Charge Behind Q3 GAAP Loss; Cash Flow Jumps to $820M
IFF sits 50% above its 52-week low of $61.295.
Summary
IFF's Q3 10-Q shows a $55 million GAAP loss driven by a $236 million charge on the Botanicals & Food Enhancements business being sold, while nine-month operating cash flow rose to $820 million and leverage held at 2.75x. The $500 million accelerated buyback settled on November 3 with about 1 million additional shares.
Key Events · Earnings and Guidance · IFF
-
Q3 GAAP Loss on Disposal Charges
Net loss attributable to IFF was $55 million, or $0.22 per diluted share, including a $236 million loss on assets classified as held for sale and a $23 million goodwill impairment tied to the Botanicals & Food Enhancements disposal group.
-
Regulatory Costs Weigh on S&A
Selling and administrative expenses rose 11% to $387 million, driven by $28 million of additional regulatory costs in the quarter; nine-month regulatory costs reached $115 million related to the fragrance business investigations.
-
Operating Cash Flow Jumps
Nine-month cash from operations was $820 million versus $532 million a year earlier, helped by working capital, while capital spending ran $449 million.
-
Leverage Inside Covenant
Total debt was $6,273 million against $519 million of cash, for net debt of $5,788 million and a 2.75x net debt to credit adjusted EBITDA ratio versus the 3.75x covenant limit.
Analysis · IFF · Industrial Applications And Services
The headline numbers were already out in this morning's 8-K, but the full 10-Q shows what actually drove the $55 million GAAP loss: a $236 million write-down on the Botanicals & Food Enhancements business being sold, a $23 million goodwill impairment, and $34 million of regulatory costs tied to the fragrance antitrust investigations. Underneath the charges, the core business is generating more cash — nine-month operating cash flow rose to $820 million from $532 million — and leverage sits at 2.75x net debt to credit adjusted EBITDA, comfortably inside the 3.75x covenant. The accelerated buyback is now complete: the final settlement on November 3 delivered about 1 million more shares at an $86.30 average, on top of the 4.8 million received in the quarter. The open question is the Food Ingredients sale to CVC, expected to close in the second quarter of 2027, whose roughly $4.18 billion of proceeds are earmarked to fund the rest of the $2.5 billion repurchase authorization and pay down the $1.0 billion term loan.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IFF was trading at $92.18 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $23.5B. The 52-week trading range was $61.30 to $95.27. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.